Make use of our viruses and derived products in your research project now . . .
A unique biological resource in the field of virology, readily available online. Users may benefit from special funding to access to products of interest, do not hesitate to apply.
After production, genotypic and phenotypic characterisations, our viruses are made available to the scientific community. It contributes to knowledge in virology and offers a valuable resource for the development of viral infection diagnostics and antiviral therapies.
We also develop and make available diagnostic and molecular detection assays for viral pathogens, in particular using P&P (ready-to-use lyophilised Primers and Probes) and ArRNA (synthetic encapsidated RNA for control) technologies.
The EVAM platform produces associated biological material (antibodies, antigens, viral DNA and RNA, reference materials) for complementary research studies.
Need an access to our platform or can't find a specific product ? Simply ask us ! Do not hesitate to contact us by using our contact information. We can create tailor-made products on demand, as well as access to platforms, or services. There are good chances that we would have what you are looking for.
EVAM is a platform of the Unité des virus
Emergents
Aix Marseille University - IRD_190 -
Inserm_1207
We collect, produce and characterise viruses of interest in human and veterinary health.
We develop diagnostic and molecular detection assays for viral pathogens.
The EVAM platform also produces biological material (antibodies, antigens, viral DNA and RNA, reference materials) for complementary research studies.
Our Facilities:
EVAM is involved in E.U. projects:
Our certifications:
AFNOR Certification certifies that the management system implemented by 
EVAM received the label We have developed new products and techniques through several collaborations and European projects.
Benbetka C, Hachid A, Benallal KE, Khardine FA, Ayhan N, Bouredjoul N, Boulehbal WM, Bellila D, Khaldi A, Charrel R.
Ayhan N, Rodríguez-Teijeiro JD, López-Roig M, Vinyoles D, Ferreres JA, Monastiri A, Charrel R, Serra-Cobo J
Alam MM, Elbadry MA, Loeb JC, Stephenson CJ, Louis R, Mavian C, Charrel R, Rahman SR, Morris JG Jr, Lednicky JA
Ayhan N, Hachid A, Thirion L, Benallal KE, Pezzi L, Khardine FA, Benbetka C, Benbetka S, Harrat Z, Charrel R
Baronti C, Coutard B, de Lamballerie X, Charrel R, Touret F.
Sett S, Dos Santos Ribeiro C, Prat C, Haringhuizen G
Thirion L, Pezzi L, Pedrosa-Corral I, Sanbonmatsu-Gamez S, de Lamballerie X, Falchi A, Perez-Ruiz M, Charrel RN
Coutard B, Romette JL, Miyauchi K, Charrel R, Prat CMA; EVA Zika Workgroup, EVA COVID-19 Workgroup
Thirion L, Dubot-Peres A, Pezzi L, Corcostegui I, Touinssi M, de Lamballerie X, Charrel RN.
Thirion L, Dubot-Peres A, Pezzi L, Corcostegui I, Touinssi M, de Lamballerie X, Charrel RN.
Thirion L, Charrel RN, Boehmann Y, Corcostegui I, Raoul H, de Lamballerie X.
Thirion L, Pezzi L, Corcostegui I, Dubot-Pérès A, Falchi A, de Lamballerie X, Charrel RN.
Three different types of accesses may be provided
to our
end-users
No profit is made by this transaction
Total price =
Shipment cost + Production
cost
Shipment charged separately
No specific eligibility condition apply for this type of access provision
No profit is made by this transaction
Total price =
Shipment cost only
. . .
The production charges are
Funded under
G.A. No 871029 
Or under G.A. No 101046133
Shipment charged separately
Specific eligibility conditions are required to
receive this type of free access
(Limited number of accesses funded)
This option can be selected during the online enquiring
process
Check your eligibility to:
EVA TNA
ISIDORe TNA
No profit is made by this transaction
Total price =
Shipment cost +
a part of our production charges
(we can bear it in
case of collaboration)
Shipment charged separately
This type of access exists under certain circumstances, apply by contacting us
Here are answers to the most common questions we receive about the EVAM platform
Academia and industries can access to our material and services. Here is a sample of our end-users:
We are all present to support your project up to completion
Technical staff
Technical staff
Technical staff
Technical staff
UVE-UMR190
Emerging Viral Diseases
Aix-Marseille Université - IRD_190 - Inserm_1207
EFS - IRBA
Medical Faculty
27 boulevard Jean Moulin
13385
Marseille cedex 5 - France
Email us for any general queries, including colaboration opportunities.
